There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.

As health insurance companies pull back on their coverage, R.I. needs to look for ways to buy in bulk and adopt a new health strategy, write doctors at the Rhode Island Public Health Institute.

Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and ...

Wearing a sage-coloured gown and clutching a bouquet of white roses and eucalyptus, Sophie Hinchliffe gazed adoringly at the ...

Federal layoffs and government shutdown concerns are compounding worker anxieties about employment stability across public ...

Ahmedabad: A recently launched weight-loss and anti-diabetic drug, Tirzepatide, has stunned the Indian pharmaceutical ...

Novo Nordisk NVO and Structure Therapeutics GPCR have emerged as noteworthy companies in the obesity space. A market leader ...

Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to ...

Danish food tech startup Matr Foods has raised €20M ($23M) in Series A funding for its mycelium meat, adding to €20M in debt ...

Chrissy Teigen is opening up about why she turned to Ozempic after losing her son Jack to miscarriage. “I had two babies and then I lost a baby a little over 20 weeks,” Teigen explained on her ...

Researchers have revealed a surprising new side effect linked to GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro and Zepbound. These popular treatments for diabetes and obesity could interfere with ...